Filing Details
- Accession Number:
- 0001708138-21-000055
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-17 16:13:08
- Reporting Period:
- 2021-08-13
- Accepted Time:
- 2021-08-17 16:13:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1226690 | George Yancopoulos | 777 Old Saw Mill River Road Tarrytown NY 10591 | President And Chief Scientific | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-08-13 | 773 | $625.00 | 936,710 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-16 | 46,925 | $625.25 | 889,785 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-16 | 2,302 | $626.10 | 887,483 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,848 | Indirect | By 401(k) Plan |
| Common Stock | 213,693 | Indirect | By Trust for Chldn. |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 46,925 shares of Company stock on August 16, 2021 at prices ranging from $625.00 to $625.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2021 at each separate price.
- Represents volume-weighted average price of sales of 2,302 shares of Company stock on August 16, 2021 at prices ranging from $626.00 to $626.14. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2021 at each separate price.
- As investment trustee of trusts for the benefit of the reporting person's children.
Billionaire Hedge Funds
